$14.13
-0.51 (-3.48%)
Open$14.62
Previous Close$14.64
Day High$14.83
Day Low$14.12
52W High$17.65
52W Low$2.95
Volume—
Avg Volume1.11M
Market Cap1.03B
P/E Ratio—
EPS$-0.26
SectorPharmaceuticals
Analyst Ratings
Buy
11 analysts
Price Target
+361.2% upside
Current
$14.13
$14.13
Target
$65.17
$65.17
$47.12
$65.17 avg
$100.64
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 179.53M | 176.40M | 195.82M |
| Net Income | 39.25M | 28.13M | 36.61M |
| Profit Margin | 21.9% | 16.0% | 18.7% |
| EBITDA | 43.74M | 50.64M | 56.07M |
| Free Cash Flow | 39.04M | 39.72M | 27.68M |
| Rev Growth | -2.9% | +12.2% | +10.8% |
| Debt/Equity | 0.71 | 0.72 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |